NGL Fine Chem Ltd

About [ edit ]

NGL Fine Chem is engaged in the Business of Chemical substances used in manufacture of pharmaceuticals and Allopathic medicines.

Key Points [ edit ]

Product Basket
NGL manufactures APIs for Animal drugs and derives 70-75% from export to countries in Europe, Asia Pacific, Middle East and Latin America. It has a product basket of 22 products and has more than 50% market share in top 4-5 products.

  • Market Cap 739 Cr.
  • Current Price 1,196
  • High / Low 1,375 / 220
  • Stock P/E 28.3
  • Book Value 199
  • Dividend Yield 0.15 %
  • ROCE 13.7 %
  • ROE 10.1 %
  • Face Value 5.00

Pros

  • Company is expected to give good quarter

Cons

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
35 39 34 43 41 37 37 35 42 68
30 32 27 33 32 33 34 33 29 48
Operating Profit 5 7 7 11 8 4 3 2 13 20
OPM % 15% 18% 21% 25% 21% 12% 9% 6% 32% 30%
Other Income 2 2 1 1 1 1 1 1 2 3
Interest 1 1 1 1 0 1 1 1 1 1
Depreciation 2 1 2 2 2 2 2 2 2 2
Profit before tax 5 7 6 10 7 3 2 0 13 21
Tax % 7% 34% 30% 30% 30% 14% 34% 165% 27% 23%
Net Profit 5 4 4 7 5 2 1 -0 9 16
EPS in Rs 8.04 7.15 6.59 11.02 8.42 3.80 1.83 -0.32 15.17 25.59
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 TTM
153 152 184
121 130 144
Operating Profit 32 22 39
OPM % 21% 14% 21%
Other Income 4 1 7
Interest 3 3 2
Depreciation 6 8 8
Profit before tax 28 12 36
Tax % 27% 31%
Net Profit 20 8 26
EPS in Rs 32.58 13.50 42.27
Dividend Payout % 5% 13%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:%
TTM:18%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:42%
Stock Price CAGR
10 Years:53%
5 Years:38%
3 Years:37%
1 Year:155%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Sep 2020
3 3 3
Reserves 89 96 120
Borrowings 27 28 24
23 26 45
Total Liabilities 142 154 192
61 68 65
CWIP 0 0 1
Investments 9 11 0
73 75 125
Total Assets 142 154 192

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020
9 20
-10 -21
0 0
Net Cash Flow -1 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020
ROCE % 14%
Debtor Days 79 63
Inventory Turnover 3.25

Shareholding Pattern

Numbers in percentages

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
65.45 65.45 65.45 65.45 65.45 65.45 73.83 73.83 73.81 73.81 73.81 73.81
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00
34.55 34.55 34.55 34.55 34.55 34.55 26.17 26.16 26.19 26.19 26.19 26.19

Documents

Add document